As Congress investigates the delay in the release of data from Merck and Schering-Plough’s now infamous Enhance trial of Vytorin, one of the key players is speaking up.
James Stein, a cardiologist at the University of Wisconsin, had reservations about the way the companies were characterizing a meeting of experts on the trial, which failed to [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment